Novozymes A/S (OTCMKTS:NVZMY) Sees Unusually-High Trading Volume – Still a Buy?

Novozymes A/S (OTCMKTS:NVZMY) saw unusually-high trading volume on Tuesday. 184,380 shares changed hands during mid-day trading, an increase of 216% from the average daily volume of 58,320 shares. The stock last traded at $66.1020 and had previously closed at $68.58.

Novozymes A/S Price Performance

The stock has a market capitalization of $27.88 billion, a price-to-earnings ratio of 39.79, a PEG ratio of 2.97 and a beta of 0.86. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.04 and a current ratio of 1.74. The company has a 50 day moving average of $67.26 and a 200 day moving average of $62.71.

Novozymes A/S (OTCMKTS:NVZMY) last posted its quarterly earnings results on Thursday, November 5th. The biotechnology company reported $0.48 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.74 by ($0.26). The company had revenue of $1.28 billion during the quarter, compared to analyst estimates of $1.28 billion. Novozymes A/S had a net margin of 15.59% and a return on equity of 6.56%. As a group, equities research analysts anticipate that Novozymes A/S will post 2.45 EPS for the current year.

Institutional Trading of Novozymes A/S

A hedge fund recently raised its stake in Novozymes A/S stock. Elefante Mark B raised its position in Novozymes A/S (OTCMKTS:NVZMY) by 73.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 5,900 shares of the biotechnology company’s stock after acquiring an additional 2,500 shares during the quarter. Elefante Mark B’s holdings in Novozymes A/S were worth $371,000 as of its most recent SEC filing. 0.03% of the stock is currently owned by institutional investors.

Novozymes A/S Company Profile

Novozymes A/S was a Denmark-based biotechnology company that developed and produced enzymes and microorganisms for industrial and consumer applications. Its solutions were used in areas including household care, food and beverages, agriculture, animal health and bioenergy. The company’s products included enzymes used in detergents, baking, brewing and biofuel production, as well as microbial solutions for agricultural and other industrial processes. Novozymes served customers in markets around the world.